Medical network on July 19 - "although our country medicine sort very much, but the general public is just more than 500 kinds of commonly used medicines, drug prices artificially high problem was amazing." In fact, as early as last year during the two conferences, the CPPCC national committee, former deputy director of the national bureau of corruption prevention hai-rong cui has publicly pointed out that the problem of drug prices artificially high.
Recently, issued by the general office of the guangdong people's government on further reform and improve the use of policy implementation plan for producing and distributing medicines, according to the notice of guangdong province put forward is one of the three goals of regulating the behavior of drug circulation and use, directed at inflated prices.
This notice is put forward such as establishing a medical representative registration and filing system; Establish drugs ex-factory price information traceability mechanism, establish a unified across departments price information platform; Strengthen the drug supervision, monitored the use of antibiotics, adjuvant drugs, nutritional drugs; Improve the quality of drug efficacy, continue to promote perfecting the system of drug registration; Implementation of public medical institutions and drug purchase points region classification; Exploring to establish a system for hospital pharmacists always, give full play to the pharmacist in the aspects of rational drug use and control functions such as task.
▍ establishes a system of registration and filing medical representatives
Promote the reform of the drug circulation system notification put forward, the public medical institutions and drug procurement "two votes"; Establishes a system of registration and filing medical representatives. A medical representative can only be engaged in the promotion, technology consultation and other activities, shall not be responsible for drug sales.
When it comes to a medical representative, a medical representative is responsible for drug firms with hospitals and pharmacies dealers for communication and coordination of work. But after a long period of development, with the drugs industry competition intensifies, the market is not standard, regulation is not enough, the function of medical representative "stale" gradually, become the pronoun of selling medicine by hook or by crook.
Many medical representative in order to better promote their products, often to the hospital, department and doctors take to please or means of bribery, even promised doctor kickbacks, and these marketing cost was added to the generated by drug sales, thereby indirectly driving up prices. Therefore, regulating the behavior of medical representatives became a to reduce drug price addition one of elements.
▍ drugs ex-factory price information traceability mechanism, establish a unified, inter-departmental price information platform
Improve low medicine policies to ensure low drug supply. Establish drugs ex-factory price information traceability mechanism, establish a unified, inter-departmental price information platform.
Drug production price information traceability mechanism eventually establish for drug prices this card is no longer mysterious, if you take this way, will not only bring a lot of pressure to pharmaceutical production enterprise, makes them feel hesitate to add, at the same time, the downstream link in the drug price negotiations have according to the can depend on, can effectively inhibit drug prices artificially high.
Wrote about the topic, the blue parker has pointed out that in today's camp, instead of two votes in the backdrop, if ministries monitoring platform drug prices tracing system, drug prices to achieve relatively transparent has no barriers, domestic production enterprises of production costs, profits, costs can be financial calculation and audit, to every link of enterprise marketing and cost control, profit how will release pressure will become the most imminent local drug firms. |
